NWRD09 injection

BIOLOGICAL2 trials

Sponsors

Newish Biotech (Wuxi) Co., Ltd.

Conditions

High-grade Squamous Intraepithelial Lesion (HSIL)

Phase 1

NWRD09 for HPV-16 Related Cervical HSIL

RecruitingNCT07047989

Newish Biotech (Wuxi) Co., Ltd.High-grade Squamous Intraepithelial Lesion (HSIL)

Start: 2025-06-12End: 2026-12-31Target: 9Updated: 2025-07-02

Phase 2

Evaluation of NWRD09 for HPV-16 Related Cervical HSIL

Not yet recruitingNCT07712692

Newish Biotech (Wuxi) Co., Ltd.High-grade Squamous Intraepithelial Lesion (HSIL)

Start: 2026-08-01End: 2027-12-30Target: 156Updated: 2026-07-17